-
Valued to be $10.3 Billion by 2026, Instrument Cluster Slated for Sedate Growth Worldwide
prnewswire
October 20, 2021
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Instrument Cluster - Global Market Trajectory & Analytics".
-
Prenetics To Be The Exclusive RT-PCR COVID-19 Testing Partner For The Standard Chartered Hong Kong, S.A.R., China Marathon 2021
prnasia
October 19, 2021
Prenetics (the "Company"), a global leader in genomic and diagnostic testing, announced today it has been appointed as the official RT-PCR COVID-19 testing partner for the Standard Chartered Hong Kong, S.A.R., China Marathon 2021...
-
FDA Authorizes New Saliva Sample Collection Method for High-Throughput, Automated COVID-19 Testing System
prnewswire
October 19, 2021
Thermo Fisher Scientific, the world leader in serving science, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to run COVID-19 tests from saliva samples...
-
Affinity Empowering Enrolls First Organization in Oklahoma for No-Cost COVID-19 Tests Through Operation Expanded Testing
prnewswire
October 19, 2021
Affinity Empowering, Inc., a leading provider of the most sophisticated and secure occupational, behavioral, and direct-to-consumer health services, today announced that Sisu Youth Services...
-
Nearly Half of American Workers Purchased at Least One New Health Benefit in Response to the COVID-19 Pandemic
prnewswire
October 19, 2021
With open enrollment season upon us, new data shows U.S. employees now believe the expansion of health care coverage, telemedicine and supplemental insurance is more important today because of the pandemic.
-
Everest Organics starts API production for Merck anti-COVID pill
CPhIonline
October 15, 2021
Manufacturer starts development of API for molnupiravir, which is set to become world’s first oral treatment against coronavirus
-
Over 50% of Hospitals will Accelerate Digital Investments to Meet the Quadruple Aim
prnasia
October 14, 2021
Frost & Sullivan's recent analysis finds that the healthcare sector's increasing focus on meeting the Quadruple Aim—enhancing patient experience, reducing costs, improving health outcomes, and improving clinician experience...
-
NeuroBo Pharmaceuticals Announces Positive Recommendation from Independent Data Safety Monitoring Committee of Phase 2/3 Clinical Trial of ANA001 in Hospitalized Patients with Moderate to Severe COVID
prnewswire
October 14, 2021
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic and neurodegenerative diseases...
-
EdHeroes Global Movement Is Expanding to Indonesia and Asia, Aiming At Creating The New Paradigm of the World of Education
prnewswire
October 14, 2021
The COVID-19 pandemic has brought drastic changes in all areas of our daily life, including the world of education. Schools, universities and educational institutions are urged to make adjustments in carrying out teaching methods and learning activities.
-
Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®
prnewswire
October 13, 2021
Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced the publication of a manuscript in the peer-reviewed journal Frontiers...